Jan Richter - Genetic Mutations

Author Information

Jan Richter is associated with the Cyprus Institute of Neurology and Genetics, specifically within the Department of Molecular Virology. The institute is located at 6 International Airport Ave., Agios Dometios, 2379 Nicosia, Cyprus. As an expert in genetics, Jan Richter has contributed significantly to the field, particularly in areas related to virology and gene therapy.

Research Contributions

Jan Richter's research has made impactful contributions to the understanding and treatment of viral infections and genetic disorders. In 2021, Richter was involved in significant studies related to SARS-CoV-2, the virus responsible for COVID-19, including its molecular epidemiology in Cyprus and the characterization of specific mutations. Additionally, Richter has explored the potential of AAV9-mediated gene therapy for demyelinating neuropathy and has investigated the efficacy of different AAV serotypes for targeting Schwann cells. Another notable area of investigation is the association of Epstein-Barr virus genes with multiple sclerosis, highlighting Richter's diverse research interests within molecular genetics and virology.

Aliases

Jan Richter is also known by the aliases J Richter and J. Richter. These variations are used interchangeably in the academic and research community to reference his work.

Publication and Citation Metrics

Metric Count
Total Citation Count 973
h-index 15
Total Paper Count 41

Publications:

DOI: 10.1371/journal.pone.0248792

Year: 2021

DOI: 10.1101/2021.03.16.21252974

Year: 2021

Partnered Content Networks

Relevant Topics